IL127914A - Intradermal bovine polynucleotide vaccine - Google Patents

Intradermal bovine polynucleotide vaccine

Info

Publication number
IL127914A
IL127914A IL12791497A IL12791497A IL127914A IL 127914 A IL127914 A IL 127914A IL 12791497 A IL12791497 A IL 12791497A IL 12791497 A IL12791497 A IL 12791497A IL 127914 A IL127914 A IL 127914A
Authority
IL
Israel
Prior art keywords
vaccine formula
virus
dna sequence
administration
vaccine
Prior art date
Application number
IL12791497A
Other languages
English (en)
Other versions
IL127914A0 (en
Original Assignee
Merial Sas
Id Dlo Inst Of Animal Science
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Sas, Id Dlo Inst Of Animal Science filed Critical Merial Sas
Publication of IL127914A0 publication Critical patent/IL127914A0/xx
Publication of IL127914A publication Critical patent/IL127914A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/265—Infectious rhinotracheitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16741—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18541—Use of virus, viral particle or viral elements as a vector
    • C12N2760/18543—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL12791497A 1996-07-19 1997-07-16 Intradermal bovine polynucleotide vaccine IL127914A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9609402A FR2751228B1 (fr) 1996-07-19 1996-07-19 Vaccin polynucleotidique bovin pour voie intradermique
PCT/FR1997/001322 WO1998003196A1 (fr) 1996-07-19 1997-07-16 Vaccin polynucleotidique bovin pour voie intradermique

Publications (2)

Publication Number Publication Date
IL127914A0 IL127914A0 (en) 1999-11-30
IL127914A true IL127914A (en) 2001-05-20

Family

ID=9494496

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12791497A IL127914A (en) 1996-07-19 1997-07-16 Intradermal bovine polynucleotide vaccine

Country Status (23)

Country Link
US (2) US6451770B1 (de)
EP (1) EP0918540B1 (de)
JP (1) JP2000515522A (de)
AP (1) AP9701045A0 (de)
AR (1) AR007863A1 (de)
AT (1) ATE224732T1 (de)
AU (1) AU722878B2 (de)
BR (1) BR9710498A (de)
CA (1) CA2261334C (de)
CO (1) CO4700344A1 (de)
CZ (1) CZ298216B6 (de)
DE (1) DE69715879T2 (de)
ES (1) ES2184122T3 (de)
FR (1) FR2751228B1 (de)
HU (1) HU224833B1 (de)
ID (1) ID19427A (de)
IL (1) IL127914A (de)
MA (1) MA24271A1 (de)
MX (1) MXPA99000684A (de)
NZ (1) NZ333752A (de)
PL (1) PL189184B1 (de)
WO (1) WO1998003196A1 (de)
ZA (1) ZA976285B (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7294338B2 (en) * 1996-07-19 2007-11-13 Merial Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies
FR2751228B1 (fr) * 1996-07-19 1998-11-20 Rhone Merieux Vaccin polynucleotidique bovin pour voie intradermique
US7078388B2 (en) * 2000-01-21 2006-07-18 Merial DNA vaccines for farm animals, in particular bovines and porcines
FR2804028B1 (fr) * 2000-01-21 2004-06-04 Merial Sas Vaccins adn ameliores pour animaux de rente
US6852705B2 (en) 2000-01-21 2005-02-08 Merial DNA vaccines for farm animals, in particular bovines and porcines
US7906311B2 (en) 2002-03-20 2011-03-15 Merial Limited Cotton rat lung cells for virus culture
EP2390352A1 (de) 2003-03-18 2011-11-30 Quantum Genetics Ireland Limited Systeme und Methoden zur Erhöhung der Milchproduktion bei Tieren
US7468273B2 (en) 2003-05-01 2008-12-23 Meial Limited Canine GHRH gene, polypeptides and methods of use
CA2545886A1 (en) 2003-11-13 2005-06-02 University Of Georgia Research Foundation, Inc. Methods of characterizing infectious bursal disease virus
EP1718770B1 (de) 2004-02-19 2011-05-25 The Governors of the University of Alberta Leptinpromotor-polymorphismen und verwendungen davon
EP1765387B1 (de) * 2004-06-04 2013-01-09 Merial Limited Nadellose verabreichung von felv-impfstofefn
WO2006115843A2 (en) 2005-04-25 2006-11-02 Merial Limited Nipah virus vaccines
US20070055200A1 (en) 2005-08-10 2007-03-08 Gilbert Scott J Needle-free jet injection drug delivery device
US20080241184A1 (en) 2005-08-25 2008-10-02 Jules Maarten Minke Canine influenza vaccines
US7771995B2 (en) 2005-11-14 2010-08-10 Merial Limited Plasmid encoding human BMP-7
EP2186823A1 (de) 2005-11-14 2010-05-19 Merial Limited Gentherapie für Nierenversagen
US7862821B2 (en) 2006-06-01 2011-01-04 Merial Limited Recombinant vaccine against bluetongue virus
SI2147105T1 (sl) 2007-05-02 2013-08-30 Merial Limited DNA-plazmidi z izboljšano ekspresijo in stabilnostjo
US20080274137A1 (en) * 2007-05-02 2008-11-06 Jean Christophe Francis Audonnet DNA plasmids having improved expression and stability
MY159543A (en) 2008-11-28 2017-01-13 Merial Inc Recombinant avian influenza vaccine and uses thereof
KR101715418B1 (ko) 2009-04-03 2017-03-10 메리얼 인코포레이티드 뉴캐슬 질환 바이러스-벡터를 이용한 조류 백신
MX351643B (es) 2009-12-28 2017-10-23 Merial Ltd Antigeno ndv recombinante y usos del mismo.
US20130197612A1 (en) 2010-02-26 2013-08-01 Jack W. Lasersohn Electromagnetic Radiation Therapy
EP2545067B1 (de) 2010-03-12 2016-11-30 Merial, Inc. Blauzungenvirus rekombinante impfstoffe und verwendungen davon
WO2012030720A1 (en) 2010-08-31 2012-03-08 Merial Limited Newcastle disease virus vectored herpesvirus vaccines
WO2012090073A2 (en) 2010-12-30 2012-07-05 The Netherlands Cancer Institute Methods and compositions for predicting chemotherapy sensitivity
WO2012138783A2 (en) 2011-04-04 2012-10-11 Netherlands Cancer Institute Methods and compositions for predicting resistance to anticancer treatment
AU2012240246A1 (en) 2011-04-04 2013-05-09 Netherlands Cancer Institute Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors
US9216213B2 (en) 2011-04-20 2015-12-22 Merial, Inc. Adjuvanted rabies vaccine with improved viscosity profile
EP2701736A1 (de) 2011-04-25 2014-03-05 Advanced Bioscience Laboratories, Inc. Trunkierte hiv-hüllproteine (env), verfahren und zugehörige zusammensetzungen
MX361804B (es) 2011-05-27 2018-12-17 Boehringer Ingelheim Animal Health Usa Inc Vacunas genéticas contra el virus hendra y el virus nipah.
US9669085B2 (en) 2011-06-01 2017-06-06 Merial Inc. Needle-free administration of PRRSV vaccines
JP6041361B2 (ja) 2011-08-12 2016-12-07 メリアル インコーポレイテッド 生物学的製品、特にはワクチンの真空保存
WO2013093629A2 (en) 2011-12-20 2013-06-27 Netherlands Cancer Institute Modular vaccines, methods and compositions related thereto
EP3466443B1 (de) 2012-02-14 2020-12-16 Boehringer Ingelheim Animal Health USA Inc. Sowohl tollwut- als auch ox40-proteine exprimierende rekombinante poxvirusvektoren und daraus hergestellte impfstoffe
KR102087458B1 (ko) 2012-02-14 2020-03-10 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 로타바이러스 아단위 백신 및 그의 제조 방법 및 용도
WO2013138776A1 (en) 2012-03-16 2013-09-19 Merial Limited Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g
BR112014031133B1 (pt) 2012-06-13 2023-02-07 The University Court Of The University Of Glasgow Vacinas reordenadas de btv e ahsv
EP2968514A1 (de) 2013-03-12 2016-01-20 Merial, Inc. Mittels reverser genetik hergestellte impfstoffzusammensetzungen gegen schmallenberg-virus und verfahren zur verwendung davon
AU2015343369B2 (en) 2014-11-03 2018-11-22 Georgia Tech Research Corporation Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
EP3738975A1 (de) 2015-06-23 2020-11-18 Boehringer Ingelheim Animal Health USA Inc. Rekombinante prrsv-virusvektoren mit minor-protein und verfahren zur herstellung und verwendung davon
PH12018500372B1 (en) 2015-08-20 2023-03-15 Merial Inc Fcv recombinant vaccines and uses thereof
ES2974666T3 (es) 2015-09-29 2024-07-01 Boehringer Ingelheim Animal Health Usa Inc Vacunas de partículas similares a virus (VLP) del parvovirus canino (CPV) y usos de las mismas
RU2714428C2 (ru) 2015-11-23 2020-02-14 Мериал, Инк. Слитые белки fmdv-e2 и их применение
TWI760322B (zh) 2016-01-29 2022-04-11 美商百靈佳殷格翰動物保健美國有限公司 重組腺病毒載體裝載之fmdv疫苗及其用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2348709A1 (fr) * 1976-04-23 1977-11-18 Pistor Michel Procede de traitement mesotherapique et dispositif d'injection,formant micro-injecteur automatique,en comportant application
FR2652257B1 (fr) * 1989-09-26 1992-11-27 Rhone Merieux Installation portative de vaccination porcine.
AU650040B2 (en) * 1990-07-24 1994-06-09 Uab Research Foundation, The Methods of use of bovine respiratory syncytial virus recombinant DNA, proteins vaccines, antibodies, and transformed cells
GB9118204D0 (en) * 1991-08-23 1991-10-09 Weston Terence E Needle-less injector
US5643578A (en) * 1992-03-23 1997-07-01 University Of Massachusetts Medical Center Immunization by inoculation of DNA transcription unit
DK0710130T3 (da) * 1993-07-31 2001-01-15 Weston Medical Ltd Nåleløs injektor
JP4050310B2 (ja) * 1994-01-27 2008-02-20 ユニバーシティ オブ マサチューセッツ メディカル センター Ｄｎａ転写ユニットの接種による免疫化
US5736524A (en) * 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
FR2751228B1 (fr) * 1996-07-19 1998-11-20 Rhone Merieux Vaccin polynucleotidique bovin pour voie intradermique

Also Published As

Publication number Publication date
JP2000515522A (ja) 2000-11-21
HUP9902792A3 (en) 2000-03-28
HUP9902792A2 (hu) 1999-12-28
PL331237A1 (en) 1999-07-05
CA2261334C (en) 2010-11-16
US6803361B2 (en) 2004-10-12
CZ10699A3 (cs) 1999-04-14
AU3773297A (en) 1998-02-10
DE69715879D1 (de) 2002-10-31
CA2261334A1 (en) 1998-01-29
MXPA99000684A (es) 2006-02-10
MA24271A1 (fr) 1998-04-01
NZ333752A (en) 2000-06-23
ES2184122T3 (es) 2003-04-01
US6451770B1 (en) 2002-09-17
ID19427A (id) 1998-07-09
CZ298216B6 (cs) 2007-07-25
AU722878B2 (en) 2000-08-10
WO1998003196A1 (fr) 1998-01-29
PL189184B1 (pl) 2005-07-29
US20020137716A1 (en) 2002-09-26
ZA976285B (en) 1999-01-19
ATE224732T1 (de) 2002-10-15
FR2751228B1 (fr) 1998-11-20
IL127914A0 (en) 1999-11-30
CO4700344A1 (es) 1998-12-29
FR2751228A1 (fr) 1998-01-23
EP0918540B1 (de) 2002-09-25
BR9710498A (pt) 2000-01-18
AR007863A1 (es) 1999-11-24
AP9701045A0 (en) 1997-07-31
HU224833B1 (en) 2006-03-28
DE69715879T2 (de) 2003-01-23
EP0918540A1 (de) 1999-06-02

Similar Documents

Publication Publication Date Title
AU722878B2 (en) Intradermal bovine polynucleotide vaccine
EP0912743B1 (de) Zusammensetzung eines polynukleotidvakzins zur behandlung von atemwegs- und fortpflanzungsbezogenen erkrankungen des schweins
AU733563B2 (en) Polynucleotide vaccine formula for treating dog diseases, particularly respiratory and digestive diseases
AU734442B2 (en) Polynucleotide vaccine formula in particular against bovine respiratory pathology
JP2000516199A (ja) ウマの予防用ポリヌクレオチドワクチン製剤
Barfoed et al. Influence of routes and administration parameters on antibody response of pigs following DNA vaccination
US20040002472A1 (en) Vaccination or immunization using a prime-boost regimen
EP1594537B1 (de) Vakzinierung oder immunisierung gegen brsv, bhv-1,bvdv,bpi-3, die ein prime-boost-verfahren verwendet
US7294338B2 (en) Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies
AU762901B2 (en) Polynucleotide vaccine formula for treating porcine respiratory and reproductive diseases
NZ750583B2 (en) Vaccine against bovine viral diarrhea virus
NZ506427A (en) A canidae vaccine comprising the rabies G gene under the control of the CMV-IE promoter

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired